Physician profile
Christopher Heath
NPI 1477845097
$678.86
in general payments reported to CMS, 2019-2025
10 companies · $94.14 in 2025
The $94.14 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $163 · 2024: $422 · 2025: $94.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.86 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $189.12 | 2023-2024 | |
| Organogenesis INC. | $178.57 | 2024-2025 | Cygnus Dual, Novachor |
| Janssen Biotech, INC. | $161.76 | 2023-2024 | Tremfya, Stelara, Simponi |
| Smith+Nephew, INC. | $26.76 | 2024 | Grafix Xc |
| Lilly USA, LLC | $25.55 | 2023 | Taltz |
| Leo Pharma INC. | $24.54 | 2024 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $22.35 | 2024 | Sotyktu |
| Genzyme Corporation | $19.74 | 2023 | |
| Botanix Sb INC | $16.63 | 2025 | Sofdra |
| Pfizer INC. | $13.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.